Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma

Background: Hyperprogressive disease (HPD) rate in head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitors (ICI) was determined using tumor growth kinetics (TGK) and compared with rapidly progressive screen-failure (SF) patients. The impact of TGK on outcomes...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Karabajakian, Andy, Garrivier, Thibaut, Crozes, Carole, Gadot, Nicolas, Blay, Jean-Yves, Bérard, Frédéric, Céruse, Philippe, Zrounba, Philippe, Saintigny, Pierre, Mastier, Charles, Fayette, Jérôme
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2020
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7210015/
https://ncbi.nlm.nih.gov/pubmed/32405337
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27563
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars